Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark A Baxter
Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
Related publications
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Pcn188 - Assessing the Robustness of a Cost-Effectiveness Analysis of Lenvatinib Versus Sorafenib in Unresectable Hepatocellular Carcinoma in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Gender-Based Outcomes Differences in Unresectable Hepatocellular Carcinoma
Hepatology International
Hepatology
Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
Journal of Gastroenterology
Gastroenterology
Regional Differences in Hepatocellular Carcinoma and Its Surgical Treatment
HPB Surgery
Surgery
Hepatology
Multimodality Treatment With Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma
Digestion
Gastroenterology
Network Meta-Analysis of Treatments for Unresectable Hepatocellular Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology
Cancer Research
Oncology
